|
Detection of immune-related adverse events among hospitalized patients using large language models. |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
Giselle Alexandra Suero-Abreu |
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Calliditas Therapeutics; Mallinckrodt; Novartis; Travere Therapeutics; Vera |
Research Funding - Abbvie; Angion; Cabaletta Bio; EMD Serono; Gilead Sciences; Novartis; Otsuka |
|
|
Consulting or Advisory Role - Bristol-Myers Squibb; Freeline Therapeutics; Intrinsic Imaging; Intrinsic Imaging |
|
|
Stock and Other Ownership Interests - 76Bio; Allogene Therapeutics; Kronos Bio |
Consulting or Advisory Role - Third Rock Ventures; Two River Consulting |
|
|
Leadership - Cerberus Therapeutics; Cerberus Therapeutics; Neoleukin Therapeutics; Veravas |
Stock and Other Ownership Interests - Johnson & Johnson; Pfizer |
Consulting or Advisory Role - Aditum Bio; Foghorn Therapeutics; Genentech/Roche; Generate Biomedicines; Mallinckrodt; Moderna Therapeutics; Partners Therapeutics; Sorriso Pharmaceuticals; SQZ Biotech |
|
|
|
Consulting or Advisory Role - Bristol-Myers Squibb; maren; Merck; Novartis; Pfizer; Replimune |
Research Funding - Aeglea Biotherapeutics (Inst); Amgen (Inst); Asana Biosciences (Inst); BeiGene (Inst); BioMed Valley Discoveries (Inst); Compugen (Inst); Deciphera (Inst); Lilly (Inst); Marengo Therapeutics (Inst); Merck (Inst); Moderna Therapeutics (Inst); Neon Therapeutics (Inst); Pfizer (Inst); Roche/Genentech (Inst); Rubius Therapeutics (Inst); Sanofi (Inst); Strategia (Inst); Strategia (Inst); Synthekine (Inst); Viralytics (Inst) |
|
|
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; C4 Therapeutics; CRC Oncology; Intrinsic Imaging; Parexel; Roche/Genentech; Sanofi |
Research Funding - AstraZeneca; Bristol Myers Squibb Foundation |
|
|
Employment - Project Data Sphere; Teladoc |
Stock and Other Ownership Interests - Biogen (I) |
Honoraria - CME Outfitters; MedScape |
Consulting or Advisory Role - SAGA Diagnostics |
Other Relationship - Project Data Sphere |
|
|
Stock and Other Ownership Interests - Johnson & Johnson |